This Management's Discussion and Analysis of Financial Condition and Results of Operations contain certain forward-looking statements. Historical results may not indicate future performance. Our forward-looking statements reflect our current views about future events; are based on assumptions and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those contemplated by these statements. Factors that may cause differences between actual results and those contemplated by forward-looking statements include, but are not limited to, those discussed in the "Risk Factors" section of our Annual Report on Form 10-K for the year endedDecember 31, 2021 . We undertake no obligation to publicly update or revise any forward-looking statements, including any changes that might result from any facts, events, or circumstances after the date hereof that may bear upon forward-looking statements. Furthermore, we cannot guarantee future results, events, levels of activity, performance, or achievements Basis of Presentation The financial information presented below and the following Management Discussion and Analysis of the Consolidated Financial Condition, Results of Operations, Stockholders' Equity and Cash Flow for the quarterly periods endedSeptember 30, 2021 and 2022 gives effect to our acquisition ofOXYS Corporation ("OXYS") onJuly 28, 2017 . In accordance with the accounting reporting requirements for the recapitalization related to the "reverse merger" of OXYS, the financial statements for OXYS have been adjusted to reflect the change in the shares outstanding and the par value of the common stock of OXYS. Additionally, all intercompany transactions between the Company and OXYS have been eliminated. Forward-Looking Statements Statements in this management's discussion and analysis of financial condition and results of operations contain certain forward-looking statements. To the extent that such statements are not recitations of historical fact, such statements constitute forward looking statements which, by definition involve risks and uncertainties. Where in any forward-looking statements, if we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation or belief will result or be achieved or accomplished. Factors that may cause differences between actual results and those contemplated by forward-looking statements include those discussed in "Risk Factors" and are not limited to the following:
· the unprecedented impact of COVID-19 pandemic on our business, customers,
employees, subcontractors and supply chain, consultants, service providers, stockholders, investors and other stakeholders; · the impact of conflict between theRussian Federation andUkraine on our operations;
· geo-political events, such as the crisis in
to such events and the related impact on the economy both nationally and
internationally;
· general market and economic conditions;
· our ability to maintain and grow our business with our current customers;
· our ability to meet the volume and service requirements of our customers;
· industry consolidation, including acquisitions by us or our competitors;
· capacity utilization and the efficiency of manufacturing operations;
· success in developing new products;
· timing of our new product introductions;
· new product introductions by competitors;
· the ability of competitors to more fully leverage low-cost geographies for
manufacturing or distribution;
· product pricing, including the impact of currency exchange rates;
· effectiveness of sales and marketing resources and strategies;
· adequate manufacturing capacity and supply of components and materials;
· strategic relationships with our suppliers;
· product quality and performance;
· protection of our products and brand by effective use of intellectual
property laws;
· the financial strength of our competitors;
· the outcome of any future litigation or commercial dispute;
· barriers to entry imposed by competitors with significant market power in
new markets; · government actions throughout the world; and · our ability to service secured debt, when due. 25 You should not rely on forward-looking statements in this document. This management's discussion contains forward looking statements that involve risks and uncertainties. We use words such as "anticipates," "believes," "plans," "expects," "future," "intends," and similar expressions to identify these forward-looking statements. Prospective investors should not place undue reliance on these statements, which apply only as of the date of this document. Our actual results could differ materially from those anticipated in these forward-looking statements.
Critical Accounting Policies
The following discussions are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted inthe United States . These financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted inthe United States . The preparation of these financial statements requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingencies. We continually evaluate the accounting policies and estimates used to prepare the financial statements. We base our estimates on historical experiences and assumptions believed to be reasonable under current facts and circumstances. Actual amounts and results could differ from these estimates made by management. Trends and Uncertainties OnJuly 28, 2017 , we closed the reverse acquisition transaction under the Securities Exchange Agreement datedMarch 16, 2017 , as reported in our Current Report on Form 8-K filed with the Commission onAugust 3, 2017 . Following the closing, our business has been that ofOXYS, Inc. andHereLab, Inc. , our wholly owned subsidiaries. Our operations have varied significantly following the closing since, prior to that time, we were an inactive shell company. Impact of COVID-19 During the year 2020, the effects of a new coronavirus ("COVID-19") and related actions to attempt to control its spread began to impact our business. The impact of COVID-19 on our operating results for the year endedDecember 31, 2021 was limited, in all material respects, due to the government mandated numerous measures, including closures of businesses, limitations on movements of individuals and goods, and the imposition of other restrictive measures, in its efforts to mitigate the spread of COVID-19 within the country. OnMarch 11, 2020 , theWorld Health Organization designated COVID-19 as a global pandemic. Governments around the world have mandated, and continue to introduce, orders to slow the transmission of the virus, including but not limited to shelter-in-place orders, quarantines, significant restrictions on travel, as well as work restrictions that prohibit many employees from going to work. Uncertainty with respect to the economic effects of the pandemic has introduced significant volatility in the financial markets.
Historical Background
We were incorporated in theState of New Jersey onOctober 1, 2003 under the name of Creative Beauty Supply ofNew Jersey Corporation and subsequently changed our name toGotham Capital Holdings, Inc. onMay 18, 2015 . We commenced operations in the beauty supply industry as ofJanuary 1, 2004 . OnNovember 30, 2007 , our Board of Directors approved a plan to dispose of our wholesale and retail beauty supply business. FromJanuary 1, 2009 untilJuly 28, 2017 , we had no operations and were a shell company. OnMarch 16, 2017 , our Board of Directors adopted resolutions, which were approved by shareholders holding a majority of our outstanding shares, to change our name to "IIOT-OXYS, Inc. ", to authorize a change of domicile fromNew Jersey toNevada , to authorize a 2017 Stock Awards Plan, and to approve the Securities Exchange Agreement (the "OXYS SEA") between the Company andOXYS Corporation ("OXYS"), aNevada corporation incorporated onAugust 4, 2016 . 26 Under the terms of the OXYS SEA, we acquired 100% of the issued voting shares of OXYS in exchange for 34,687,244 shares of our Common Stock. We also cancelled 1,500,000 outstanding shares of our Common Stock and changed our management toMr. DiBiase who also served in management of OXYS. Also, one of our principal shareholders entered into a consulting agreement with OXYS to provide consulting services during the transition. The OXYS SEA was effective onJuly 28, 2017 , and our name was changed to "IIOT-OXYS, Inc. " at that time. EffectiveOctober 26, 2017 , our domicile was changed fromNew Jersey toNevada . OnDecember 14, 2017 , we entered into a Share Exchange Agreement (the "HereLab SEA") withHereLab, Inc. , aDelaware corporation ("HereLab"), and HereLab's two shareholders pursuant to which we would acquire all the issued and outstanding shares of HereLab in exchange for the issuance of 1,650,000 shares of our Common Stock, on a pro rata basis, to HereLab's two shareholders. The closing of the transaction occurred onJanuary 11, 2018 and HereLab became our wholly-owned subsidiary.
At the present time, we have two, wholly-owned subsidiaries which are
General OverviewIIOT-OXYS, Inc. , aNevada corporation (the "Company"), and OXYS, were originally established for the purposes of designing, building, testing, and selling Edge Computing systems for the Industrial Internet. Both companies were, and presently are, early-stage technology startups that are largely pre-revenue in their development phase. HereLab is also an early-stage technology development company. We received our first revenues in the last quarter of 2017, continued to realize revenues until 2020 when the pandemic hit, and we realized nominal revenues through 2021. We develop hardware, software and algorithms that monitor, measure and predict conditions for energy, structural, agricultural and medical applications. We use domain-specific Artificial Intelligence to solve industrial and environmental challenges. Our engineered solutions focus on common sense approaches to machine learning, algorithm development and hardware and software products. We use off the shelf components, with reconfigurable hardware architecture that adapts to a wide range of customer needs and applications. We use open-source software tools, while still creating proprietary content for customers, thereby reducing software development time and cost. The software works with the hardware to collect data from the equipment or structure that is being monitored. We focus on developing insights. We develop algorithms that help our customers create insights from vast data streams. The data collected is analyzed and reports are created for the customer. From these insights, the customer can act to improve their process, product or structure.
Results of Operations for the Three Months Ended
The Company reported$23,003 and$5,280 in service revenues with cost of sales of$5,140 and$1,275 for the three months endedSeptember 30, 2022 and 2021, respectively. The Company incurred general and administrative expenses ("G&A") of$158,818 for the three months endedSeptember 30, 2022 as compared to$208,531 for the same comparable period in 2021. The net decrease of$49,713 in G&A expenses resulted primarily due to a reduction in professional fees paid to consultants of$40,778 and reduction in payroll and stock compensation earned by the Officers and Director of$2,946 . The Company recorded a gain of$125,568 due to the change in the fair market value of derivative liabilities during the three months endedSeptember 30, 2022 as compared to a loss of$18,103 for the same comparable period in 2021. The Company recorded interest income of$5,986 for the three months endedSeptember 30, 2022 due to the unsecured promissory note extended to a third party earning 10% interest per annum compared to$0 interest earned in the comparable period of 2021. The Company recorded an interest expense of$14,913 for the three months endedSeptember 30, 2022 as compared to$100,701 for the same comparable period in 2021. The interest expense decreased because the Company did not record any amortization of debt discount during the three months endedSeptember 30, 2022 as compared to recording$82,329 in amortization of debt discounts to interest expense during the three months endedSeptember 30, 2021 . 27
Results of Operations for the Nine Months Ended
The Company recorded
The Company incurred general and administrative expenses ("G&A") of$543,449 for the nine months endedSeptember 30, 2022 as compared to$737,746 for the same comparable period in 2021. The decrease in G&A expenses resulted primarily due to reduction in professional and consulting fees of$316,400 in the nine months endedSeptember 30, 2022 as compared to the same comparable period in 2021. This reduction of expense was offset by an increase in payroll costs of$99,723 during the nine months endedSeptember 30, 2022 as compared to the same comparable period in 2021. The Company recorded a gain of$277,424 due to the change in the fair market value of derivative liabilities during the nine months endedSeptember 30, 2022 as compared to a gain of$172,558 for the same comparable period in 2021. The Company recorded a loss on derivatives of$207,447 and$0 for the nine months endedSeptember 30, 2022 and 2021, respectively, due to the change in mark to market of the fair value of derivative liabilities. In addition, the Company recorded a gain of$120,000 on the extinguishment of debt upon agreeing with the note holders to a reduction in the debt conversion price during the nine months endedSeptember 30, 2021 , whereas, no such gain or loss was recorded for the same comparable period in 2022. The Company recorded an interest income of$11,647 for the nine months endedSeptember 30, 2022 as compared to$0 for the same comparable period in 2021. The Company recorded interest expense of$278,605 and$333,039 for the nine months endedSeptember 30, 2022 and 2021, respectively. The interest expense decreased due to the Company recording reduction in the fair market value of the derivative liability to interest expense. As a result, the Company recorded a loss of$775,217 for the nine months endedSeptember 30, 2022 as compared to a loss of$818,211 for the same comparable period in 2021. Our revenue for the quarter endedSeptember 30, 2022 exceeded the total revenue for 2021, as was anticipated in our Quarterly Report on Form 10-Q for the first quarter of 2022. We continue to gain traction with strategic partners, customers, and potential customers in our key two markets: Smart Manufacturing / Industry 4.0 and Structural Health Monitoring (SHM). These are both high growth markets. Market research shows the worldwide Industry 4.0 market in 2021 was$64.9 billion USD and is projected to be$165.5 billion USD by 2026 (20.6% CAGR).[1] Also, the worldwide Structural Health Monitoring industry was$2.0 billion USD in 2021 and will reach$4.0 billion USD by 2027 (CAGR of 14.6%).[2]Through our collaborations with Aretas Sensor Networks, we have access to a third market, Indoor Air Quality Monitors, which is estimated at$3.7 billion USD in 2020 and projected to reach$6.4 billion USD in 2027, growing at 8.2% CAGR.[3]
Year to Date Accomplishments in 2022:
· We announced in the first quarter that we entered into an NDA with an EU
Electrical Technology Original Equipment Manufacturer. Collaborative
discussions continue and we expect this agreement to lead to new business
in due time. · The Canadian Indoor Air Quality Sensor and IIoT Platform company, Aretas
Sensor Networks, with whom we entered into an NDA in the first quarter,
continues to progress as well. In addition to the initial collaborative
agreement signed in the first quarter, we signed an algorithm development
contract in the second quarter and recorded revenue from that contract in
this quarter. We also signed a co-marketing and co-selling agreement with
Aretas in this quarter and expect revenue from sales commissions in the fourth quarter.
· Our Structural Health Monitoring business continues to gather momentum,
receiving a contract extension with a New England State's DOT for Bridge
Monitoring announced in the first quarter for monitoring throughout the
second quarter. A proposal for monitoring and equipment upgrades for the
2022 to 2023 fiscal year was submitted in the second quarter and received
the formal contract in the third quarter of 2022. We have recorded revenue
on this contract since July and will continue to receive revenue from the
contract through June of 2023. · We continue to secure significant and supportive funding.
· Our full time Machine Learning Engineer, hired in the first quarter,
continues to expand our focus on the Artificial Intelligence (AI) and Machine Learning (ML) aspects of our business · Our CEO,Cliff Emmons , and COO,Karen McNemar , both renewed their
employment contracts in June, ensuring stable experienced leadership
focused on long-term growth. _________________________
[1]https://www.marketsandmarkets.com/Market-Reports/industry-4-market-102536746.html
[2]https://www.marketsandmarkets.com/Market-Reports/structural-health-monitoring-market-101431220.html
[3]https://www.reportlinker.com/p05957040/Global-Indoor-Air-Quality-Monitors-Industry.html
28 We believe the underlying strengths of the Company are gathering momentum for expected growth: an experienced leadership team; contributions of our new Machine Learning Engineer, a PhD level Machine Learning Algorithms specialist; strong execution on contracts to date; and a steady focus on prospecting, submitting proposals, and securing Proof of Concepts (POCs). Those completed contracts to date have produced two successful pilot programs: one on manufacturing operations for our Fortune 500 Pharma customer, and a pilot with a full year of data collection and analysis on our structural health monitoring program for aNew England state's DOT - which has now led to a bridge monitoring contract extension, which includes equipment upgrades and additional analysis. Our continued focus on high potential growth markets (specifically Biotech, Pharma, and Medical Device Operations, Structural Health Monitoring, and Indoor Air Quality), has yielded numerous prospects for future growth. Specifically, we secured an AI - Machine Learning sub-contract and initiated a POC for our IAQ strategic partner in the second quarter and signed a co-marketing and co-selling agreement with the same strategic partner in the third quarter. We are pleased that the momentum of the second quarter's revenue continued into the third quarter and expect it will continue through the fourth quarter. Our third quarter revenue exceeded our second quarter revenue and expect revenue for the second half of 2022 will exceed that generated in the first half of 2022. In total, we expect that total revenue for 2022 will be approaching 2019 levels. This is due to the hard work of the past year that has resulted in two successful pilots, in two of our key target industry verticals. We now have data and algorithms to build strong use cases and marketing collateral that can be leveraged to extend contracts with current customers and win additional contracts with new customers in all targeted industry segments. Also, the strength of the collaboration agreements with both Aingura IIoT, S.G. and Aretas Sensor Networks have substantially bolstered financial stability, added talent breadth and depth, and complimentary industry segment experience. Furthermore, the continued liquidity of our stock has attracted funding opportunities, and access to additional capital has and will enable funding of business development, intellectual property development, staff augmentation, and inorganic growth opportunities. Combined with our underlying strengths: experienced leadership; savvy technological talent, and operational execution excellence; we believe these revenue goals are achievable.
As of
Liquidity and Capital Resources
AtSeptember 30, 2022 , the Company had a cash balance of$34,284 , which represents a$12,537 reduction from the$46,821 balance atDecember 31, 2021 . This reduction was primarily the result of cash provided by the sale of common stock of$481,657 and Series B preferred stock (net of offering costs of$9,633 ) in the aggregate amount of$187,000 , offset by net cash used in operating activities of$471,561 due to acceleration in product development activities, and cash used in investing activities by executing a note receivable of$200,000 from Aretas. The Company's working capital atSeptember 30, 2022 was a deficit of$1,473,996 , as compared to a working capital deficit of$1,108,786 atDecember 31, 2021 . The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As shown in the accompanying financial statements, the Company has incurred losses from operations of$775,217 for the nine months endedSeptember 30, 2022 , and has an accumulated deficit of$9,005,473 atSeptember 30, 2022 , which raises substantial doubt about the Company's ability to continue as a going concern. Management believes the Company will continue to incur losses and negative cash flows from operating activities for the foreseeable future and will need additional equity or debt financing to sustain its operations until it can achieve profitability and positive cash flows, if ever. Management plans to seek additional debt and/or equity financing for the Company but cannot assure that such financing will be available on acceptable terms. At the Company's current rate of expenditure, the Company anticipates being able to maintain current operations for three months; however, management is proposing to raise any necessary additional funds not provided by operations through loans or through additional sales of equity securities. There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable operations. The Company's continuation as a going concern is dependent upon its ability to ultimately attain profitable operations, generate sufficient cash flow to meet its obligations, and obtain additional financing as may be required. Our auditors have included a going concern qualification in their auditors' report datedApril 14, 2022 . Such a going concern qualification may make it more difficult for us to raise funds when needed. The outcome of this uncertainty cannot be assured.
The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty. There can be no assurance that management will be successful in implementing its business plan or that the successful implementation of such business plan will actually improve the Company's operating results.
29
Recently Issued Accounting Standards
Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our consolidated financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity capital expenditures or capital resources. Emerging Growth Company We are an "emerging growth company," as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. Certain specified reduced reporting and other regulatory requirements that are available to public companies that are emerging growth companies. These provisions include:
1. an exemption from the auditor attestation requirement in the assessment of
our internal controls over financial reporting required by Section 404 of the Sarbanes-Oxley Act of 2002;
2. an exemption from the adoption of new or revised financial accounting
standards until they would apply to private companies;
3. an exemption from compliance with any new requirements adopted by the
mandatory audit firm rotation or a supplement to the auditor's report in
which the auditor would be required to provide additional information
about our audit and our financial statements; and 4. reduced disclosure about our executive compensation arrangements. We have elected to take advantage of the exemption from the adoption of new or revised financial accounting standards until they would apply to private companies. As a result of this election, our financial statements may not be comparable to public companies required to adopt these new requirements. 30
© Edgar Online, source